Searchable abstracts of presentations at key conferences in endocrinology

ea0020p128 | Thyroid | ECE2009

Coexistence of hyperparathyroidism and non-medullary thyroid carcinoma

Alevizos Leonidas , Markogiannakis Haridimos , Kekis Panagiotis , Papadima Artemisia , Sigala Frantzeska , Filis Konstantinos , Toutouzas Konstantinos , Manouras Andreas

Background – objective: Medullary thyroid carcinoma and hyperparathyroidism coexistence is well described in the literature. On the other hand, data regarding the coexistence of non-medullary thyroid cancer and hyperparathyroidism are scarce. The aim of this study was to evaluate the occurrence of such coexistence.Methods: This is a retrospective study of all patients with primary or secondary hyperparathyroidism who underwent parathyroidectomy in o...

ea0014p535 | (1) | ECE2007

Neurotropic profiles of androgens - mechanisms and targets

Goetz Franziska , Patchev Vladimir K , Rohde Wolfgang , Patchev Alexandre V

Identification of pure neural androgenic effects is difficult due to 1) regional distribution of androgen receptors (AR) in the CNS; 2) cross-talk between molecular pathways of steroid hormone signalling, and 3) chemical nature and biotransformation of androgens in the CNS. Testosterone is transformed in the CNS by 5α-reductase and aromatase to the pure AR-agonist dihydrotestosterone (DHT) and the estrogen receptor-agonist estradiol, respectively. Decreased sexual activit...

ea0012s28 | Controlling the overactive parathyroid | SFE2006

Consequences of primary and secondary hyperparathyroidism

Hosking D

The sustained over-secretion of PTH is a common clinical problem with particular consequences for the skeleton. Hyperparathyroidism (HPT) increases the bone surface undergoing remodelling, amplifies the negative balance at the bone multicellular unit and increases activation frequency, eroded surface and formation, without increased trabecular perforation. Cortical bone is particularly susceptible to the effects of hyperparathyroidism and bone mineral density (BMD) measurement...

ea0011s90 | Contrasting practices in European endocrinology | ECE2006

New endocrinology medicines: when are they good value?

Walker A

Health care payers (governments or insurance plans) are increasingly challenging new health services, including medicines, to prove their value and several European countries have established agencies to help with this task. The example of NICE in England is one example but the Scottish Medicines Consortium (SMC) offers another.In its first four years the SMC has considered 14 endocrinology products, accepting eleven for use (79%). Manufacturers submit e...

ea0010s31 | Big issues in pituitary research | SFE2005

Folliculostellate cells: what are they?

Rees D

Pituitary folliculostellate (FS) cells were originally described in 1953 and comprise up to 10% of the anterior pituitary cell population. These epithelioid cells are thought to be derived from neuroectodermal cells and express S-100, a nervous tissue-selective protein that is used to define FS phenotype. Unlike their endocrine counterparts, they are devoid of secretory granules and were considered non-secretory until relatively recently. Experiments using pituitary slices hav...

ea0005p88 | Diabetes, Metabolism and Cardiovascular | BES2003

Mechanisms of splicing inhibition in apolipoprotein B exon 26 (ApoB ex26)

Khoo B , Akker S , Chew S

ApoB isoforms are components of the chylomicron, and of the atherogenic LDL and Lp(a) particles. Ex26 is exceptionally long at 7.57kb as most exons are <500bp. Ex26 is also the site of RNA editing, which generates the ApoB48 isoform instead of ApoB100. The first 3kb of ex26 contains 15 sequences matching the splice site consensus, which could be used in splicing, but are not. Splice sites matching the consensus but which are not used are called pseudosites. How the spliceos...

ea0005p100 | Diabetes, Metabolism and Cardiovascular | BES2003

Treatment of coronary disease and effects on endogenous testosterone levels

Malkin C , Pugh P , Jones T , Channer K

Background. Males with coronary disease have lower levels of endogenous testosterone than unaffected males. It is not known if low testosterone is a cause, effect or an epi-phenomenon of ischaemic heart disease.We hypothesised that androgen deficient men treated surgically with complete resolution of their symptoms would have a higher subsequent testosterone than men with persistent angina.Methods. Subjects were recruited after angiography. All subjects were biochemically ...

ea0056d5.2 | Pregnant women should be screened for thyroid hormones and antibodies | ECE2018

AGAINST: ‘Pregnant women should be screened for thyroid hormones and antibodies’

Velkeniers Brigitte , Unuane David

Screening is a process of identifying apparently healthy people at increased risk of a disease or condition. They can then be offered appropriate treatment to reduce the risk arising from the disease or condition.Thyroid autoimmunity (TAI), defined by the presence of antibodies against thyroperoxidase and thyroglobulin, have been associated with adverse pregnancy outcomes, infertility, and impaired child neurodevelopment. However, associations do not nec...

ea0055p18 | Poster Presentations | SFEEU2018

Type 1 diabetes presenting with unilateral left foot drop

Li Adrian P Z , Best Jonathan , Kariyawasam Dulmini , Brackenridge Anna , Thomas Stephen , Maltese Giuseppe

Case history: A 26-year-old lady presented with a two-week history of weakness associated with pins and needles affecting the lateral calf and dorsomedial aspect of her left foot. The patient denied any trauma or symptoms including weight loss. She had no drug allergies and was taking no regular medications. She had a vegan diet supplemented with multivitamins. Her past medical and family history was unremarkable. On examination, she had a narrow-based high-steppage-gait. Lowe...

ea0090oc6.1 | Oral Communications 6: Endocrine-related Cancer | ECE2023

RNA splicing landscape of pancreatic neuroendocrine neoplasms reveal novel clinico-molecular associations

Blazquez-Encinas Ricardo , Pedraza-Arevalo Sergio , Garcia Vioque Victor , Trinidad Moreno Montilla Maria , Lawlor Rita T , Rovite Vita , Scarpa Aldo , Ibanez Costa Alejandro , P. Castano Justo

Neuroendocrine neoplasms (NENs) are a highly heterogeneous group of tumors that arise from the diffuse neuroendocrine system and whose incidence has increased over the last years. Among them, pancreatic NENs (PanNENs) are relatively common and one of the most studied NENs. PanNENs are characterized by a low number of mutations, with some genes frequently mutated, such as MEN1, ATRX/DAXX, and mTOR signaling pathway genes. Despite genomics, transcripto...